| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tyrosine hydroxylase | 0.462 | 0.885 | 1.7E-06 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2011 | 2019 | ||||||||
|
adrenoceptor beta 1 | 0.555 | 0.769 | 2.9E-06 |
|
disease | 0.600 | None | 0.940 | 1 | 0 | 1991 | 2019 | ||||||||
|
renalase, FAD dependent amine oxidase | 0.678 | 0.423 | 3.8E-06 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
discoidin domain receptor tyrosine kinase 1 | 0.497 | 0.808 | 4.6E-06 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2002 | 2006 | ||||||||
|
natriuretic peptide B | 0.513 | 0.808 | 9.9E-06 |
|
disease | 0.600 | None | 0.986 | 1 | 0 | 1991 | 2020 | ||||||||
|
haptoglobin | 0.412 | 0.885 | 1.7E-05 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2005 | 2015 | ||||||||
|
BCL2 interacting protein 3 | 0.520 | 0.731 | 2.0E-05 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
galectin 3 | 0.392 | 0.846 | 2.3E-05 |
|
disease | 0.300 | None | 0.972 | 1 | 0 | 2004 | 2020 | ||||||||
|
G protein-coupled receptor kinase 1 | 0.695 | 0.423 | 3.1E-05 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
interleukin 6 receptor | 0.471 | 0.846 | 3.2E-05 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
MAS1 proto-oncogene, G protein-coupled receptor | 0.533 | 0.769 | 8.3E-05 |
|
disease | 0.240 | None | 1.000 | 1 | 0 | 2011 | 2020 | ||||||||
|
cholinergic receptor nicotinic alpha 4 subunit | 0.492 | 0.808 | 8.5E-05 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
caspase 12 (gene/pseudogene) | 0.638 | 0.808 | 1.3E-04 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2008 | 2016 | ||||||||
|
cysteine and glycine rich protein 3 | 0.572 | 0.731 | 1.6E-04 |
|
disease | 0.300 | None | 1.000 | 0 | 0 | 1997 | 2019 | ||||||||
|
sirtuin 3 | 0.488 | 0.731 | 1.6E-04 |
|
disease | 0.250 | None | 1.000 | 1 | 0 | 2012 | 2019 | ||||||||
|
endonuclease G | 0.656 | 0.500 | 1.8E-04 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
poly(ADP-ribose) polymerase 1 | 0.389 | 0.923 | 3.3E-04 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2005 | 2018 | ||||||||
|
TIMP metallopeptidase inhibitor 4 | 0.559 | 0.769 | 3.8E-04 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2000 | 2018 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
disease | 0.600 | None | 0.971 | 1 | 0 | 1997 | 2019 | ||||||||
|
natriuretic peptide A | 0.505 | 0.769 | 5.5E-04 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 1989 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily E regulatory subunit 1 | 0.588 | 0.615 | 3.4E-03 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2006 | 2010 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.280 | None | 0.909 | 3 | 0 | 1996 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.300 | None | 0.818 | 1 | 0 | 1999 | 2019 | ||||||||
|
malate dehydrogenase 2 | 0.595 | 0.731 | 6.7E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
angiotensin II receptor type 2 | 0.496 | 0.808 | 8.2E-03 |
|
disease | 0.230 | None | 0.800 | 2 | 0 | 2000 | 2017 |